United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE320.9900
- TODAY'S CHANGE (%)-2.0900 (-0.6469%)
- Bid / Lots312.2600/ 3
- Ask / Lots324.2500/ 2
- Open / Previous Close323.7300 / 323.0800
- Day Range
- 52 Week Range
- Volume878,909
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 1766 | 323.73 |
| 09:38 ET | 100 | 322.11 |
| 09:39 ET | 100 | 322 |
| 09:48 ET | 100 | 321.91 |
| 09:52 ET | 247 | 321.23 |
| 09:57 ET | 1743 | 320.52 |
| 10:01 ET | 220 | 320.53 |
| 10:03 ET | 400 | 321.51 |
| 10:06 ET | 100 | 321.59 |
| 10:08 ET | 1142 | 320.55 |
| 10:10 ET | 1228 | 320.47 |
| 10:12 ET | 100 | 319.57 |
| 10:14 ET | 100 | 319.46 |
| 10:15 ET | 100 | 319.61 |
| 10:21 ET | 800 | 319.295 |
| 10:24 ET | 200 | 319.215 |
| 10:30 ET | 837 | 317.53 |
| 10:32 ET | 100 | 317.5 |
| 10:33 ET | 2785 | 317.035 |
| 10:35 ET | 2995 | 316.39 |
| 10:37 ET | 1000 | 317.085 |
| 10:39 ET | 2210 | 317.04 |
| 10:42 ET | 600 | 316.32 |
| 10:44 ET | 933 | 317 |
| 10:46 ET | 2976 | 317.25 |
| 10:48 ET | 2242 | 318.175 |
| 10:55 ET | 600 | 318.58 |
| 11:02 ET | 325 | 318.01 |
| 11:04 ET | 1306 | 317.495 |
| 11:09 ET | 100 | 317.595 |
| 11:11 ET | 300 | 318.01 |
| 11:15 ET | 500 | 318.355 |
| 11:18 ET | 250 | 318.115 |
| 11:20 ET | 200 | 318.09 |
| 11:22 ET | 400 | 318 |
| 11:24 ET | 100 | 318.17 |
| 11:26 ET | 1420 | 318.295 |
| 11:27 ET | 1753 | 319.09 |
| 11:29 ET | 200 | 320 |
| 11:33 ET | 206 | 319.57 |
| 11:38 ET | 604 | 319.88 |
| 11:40 ET | 100 | 319.83 |
| 11:44 ET | 100 | 319.875 |
| 11:47 ET | 300 | 319.775 |
| 11:51 ET | 400 | 319.935 |
| 11:54 ET | 700 | 320.39 |
| 11:56 ET | 408 | 320.04 |
| 11:58 ET | 100 | 320.04 |
| 12:00 ET | 1335 | 319.94 |
| 12:02 ET | 100 | 320.045 |
| 12:05 ET | 100 | 319.7 |
| 12:09 ET | 500 | 320.37 |
| 12:12 ET | 901 | 320.0716 |
| 12:16 ET | 200 | 319.99 |
| 12:20 ET | 1700 | 320.81 |
| 12:21 ET | 100 | 320.38 |
| 12:23 ET | 400 | 320.39 |
| 12:25 ET | 108 | 320.525 |
| 12:27 ET | 100 | 320.6999 |
| 12:30 ET | 3085 | 319.91 |
| 12:32 ET | 1678 | 319.665 |
| 12:34 ET | 100 | 319.75 |
| 12:36 ET | 373 | 320.1 |
| 12:38 ET | 100 | 320.21 |
| 12:39 ET | 500 | 319.625 |
| 12:41 ET | 417 | 320.31 |
| 12:43 ET | 100 | 319.94 |
| 12:48 ET | 200 | 319.94 |
| 12:50 ET | 100 | 320.095 |
| 12:52 ET | 100 | 320.195 |
| 12:54 ET | 200 | 320.44 |
| 12:59 ET | 100 | 321.345 |
| 01:01 ET | 1500 | 321.285 |
| 01:03 ET | 100 | 320.785 |
| 01:06 ET | 800 | 320.58 |
| 01:08 ET | 100 | 320.9 |
| 01:12 ET | 750 | 320.625 |
| 01:14 ET | 500 | 320.475 |
| 01:15 ET | 100 | 320.28 |
| 01:17 ET | 200 | 320.64 |
| 01:19 ET | 100 | 320.9 |
| 01:21 ET | 100 | 321.29 |
| 01:24 ET | 200 | 321.875 |
| 01:26 ET | 200 | 321.88 |
| 01:30 ET | 100 | 322.22 |
| 01:33 ET | 300 | 321.87 |
| 01:35 ET | 300 | 321.62 |
| 01:37 ET | 500 | 322.36 |
| 01:39 ET | 615 | 322.245 |
| 01:42 ET | 600 | 321.92 |
| 01:46 ET | 700 | 322.6 |
| 01:48 ET | 1300 | 322.66 |
| 01:51 ET | 804 | 321.46 |
| 01:53 ET | 100 | 321.45 |
| 01:55 ET | 100 | 321.07 |
| 02:13 ET | 193 | 321.45 |
| 02:18 ET | 300 | 321.61 |
| 02:20 ET | 100 | 321.805 |
| 02:22 ET | 100 | 321.6 |
| 02:24 ET | 100 | 321.625 |
| 02:29 ET | 197 | 321.65 |
| 02:31 ET | 719 | 321.85 |
| 02:36 ET | 200 | 321 |
| 02:38 ET | 1449 | 321.475 |
| 02:40 ET | 109 | 322.12 |
| 02:44 ET | 100 | 322.16 |
| 02:47 ET | 600 | 322.71 |
| 02:49 ET | 5500 | 322.71 |
| 02:51 ET | 1000 | 323.15 |
| 03:00 ET | 5229 | 322.6 |
| 03:02 ET | 1700 | 322.48 |
| 03:03 ET | 600 | 322.235 |
| 03:05 ET | 207 | 322.315 |
| 03:07 ET | 800 | 322.04 |
| 03:09 ET | 600 | 321.55 |
| 03:12 ET | 900 | 321.33 |
| 03:14 ET | 800 | 321.21 |
| 03:16 ET | 2800 | 321.33 |
| 03:18 ET | 800 | 321.125 |
| 03:27 ET | 175 | 320.775 |
| 03:30 ET | 300 | 320.22 |
| 03:34 ET | 1385 | 320.3 |
| 03:36 ET | 500 | 320.125 |
| 03:38 ET | 1774 | 320.335 |
| 03:39 ET | 1757 | 320.435 |
| 03:41 ET | 1019 | 320.845 |
| 03:43 ET | 1100 | 320.64 |
| 03:45 ET | 2643 | 320.81 |
| 03:48 ET | 1200 | 320.41 |
| 03:50 ET | 2025 | 320.545 |
| 03:52 ET | 4741 | 321.67 |
| 03:54 ET | 8922 | 321.58 |
| 03:56 ET | 1300 | 321.4 |
| 03:57 ET | 5098 | 321.01 |
| 03:59 ET | 76211 | 320.99 |
Aug 1, 2024
DJ United Therapeutics Price Target Maintained With a $400.00/Share by HC Wainwright & Co., from 9:19AM ET on Thursday Aug 01, 2024 by Dow Jones
9:19AM ET on Thursday Aug 01, 2024 by Dow JonesDJ United Therapeutics Is Maintained at Underperform by B of A Securities, from 7:38AM ET on Thursday Aug 01, 2024 by Dow Jones
7:38AM ET on Thursday Aug 01, 2024 by Dow Jones
Jul 31, 2024
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results, from 6:30AM ET on Wednesday Jul 31, 2024 by Dow Jones
6:30AM ET on Wednesday Jul 31, 2024 by Dow Jones*DJ United Therapeutics 2Q EPS $5.85 >UTHR, from 6:30AM ET on Wednesday Jul 31, 2024 by Dow Jones
6:30AM ET on Wednesday Jul 31, 2024 by Dow Jones
Jul 25, 2024
DJ United Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:37AM ET on Thursday Jul 25, 2024 by Dow Jones
6:37AM ET on Thursday Jul 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 14.3B | 14.8x | +8.22% |
Biomarin Pharmaceutical Inc | 17.0B | 67.5x | --- |
Neurocrine Biosciences Inc | 14.6B | 43.8x | +62.04% |
Exact Sciences Corp | 10.9B | -61.2x | --- |
Medpace Holdings Inc | 12.0B | 36.4x | +35.10% |
Qiagen NV | 10.5B | 31.0x | +12.66% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.3B |
|---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.56 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 14.8x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | 12.6x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
